Results 41 to 50 of about 101 (77)
Factors that influence treatment delay in patients with colorectal cancer. [PDF]
Oncotarget, 2017 Zarcos-Pedrinaci I, Fernández-López A, Téllez T, Rivas-Ruiz F, Rueda A, Morales Suarez-Varela MM, Briones E, Baré M, Escobar A, Sarasqueta C, de Larrea NF, Aguirre U, Quintana JM, Redondo M, CARESS-CCR Study Group. +14 moreeuropepmc +1 more sourceFactors Associated with Prolonged Patient-Attributable Delay in the Diagnosis of Colorectal Cancer. [PDF]
Cancer Res Treat, 2018 Zarcos-Pedrinaci I, Téllez T, Rivas-Ruiz F, Padilla-Ruiz MDC, Alcaide J, Rueda A, Baré ML, Suárez-Varela MMM, Briones E, Sarasqueta C, Fernández-Larrea N, Escobar A, Quintana JM, Redondo M. +13 moreeuropepmc +1 more sourceMODUL-a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach. [PDF]
J Cancer Res Clin Oncol, 2018 Schmoll HJ, Arnold D, de Gramont A, Ducreux M, Grothey A, O'Dwyer PJ, Van Cutsem E, Hermann F, Bosanac I, Bendahmane B, Mancao C, Tabernero J. +11 moreeuropepmc +1 more sourceBiomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib. [PDF]
Oncotarget, 2018 Jiménez-Fonseca P, Martín MN, Carmona-Bayonas A, Calvo A, Fernández-Mateos J, Redrado M, Capdevila J, Lago NM, Lacasta A, Muñarriz J, Segura Á, Fuster J, Barón F, Llanos M, Serrano R, Castillo A, Cruz Hernández JJ, Grande E. +17 moreeuropepmc +1 more sourceFirst-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study. [PDF]
Oncologist, 2012 Díaz-Rubio E, Gómez-España A, Massutí B, Sastre J, Abad A, Valladares M, Rivera F, Safont MJ, Martínez de Prado P, Gallén M, González E, Marcuello E, Benavides M, Fernández-Martos C, Losa F, Escudero P, Arrivi A, Cervantes A, Dueñas R, López-Ladrón A, Lacasta A, Llanos M, Tabernero JM, Antón A, Aranda E, Spanish Cooperative Group for the Treatment of Digestive Tumors. +25 moreeuropepmc +1 more sourceOne Hundred Years After Its Discovery in Guatemala by Rodolfo Robles, Onchocerca volvulus Transmission Has Been Eliminated from the Central Endemic Zone. [PDF]
Am J Trop Med Hyg, 2015 Richards F, Rizzo N, Diaz Espinoza CE, Monroy ZM, Crovella Valdez CG, de Cabrera RM, de Leon O, Zea-Flores G, Sauerbrey M, Morales AL, Rios D, Unnasch TR, Hassan HK, Klein R, Eberhard M, Cupp E, Domínguez A. +16 moreeuropepmc +1 more sourceCombining statistical techniques to predict postsurgical risk of 1-year mortality for patients with colon cancer. [PDF]
Clin Epidemiol, 2018 Arostegui I, Gonzalez N, Fernández-de-Larrea N, Lázaro-Aramburu S, Baré M, Redondo M, Sarasqueta C, Garcia-Gutierrez S, Quintana JM, REDISSEC CARESS-CCR Group. +9 moreeuropepmc +1 more source